tiprankstipranks
Aptabio Therapeutics, Inc. (KR:293780)
:293780
South Korea Market

Aptabio Therapeutics, Inc. (293780) Earnings Dates, Call Summary & Reports

Followers

Earnings Data

Report Date
Nov 18, 2026
TBA (Confirmed)
Period Ending
2026 (Q3)
Consensus EPS Forecast
Last Year’s EPS
-114.13
Same Quarter Last Year
Based on 0 Analysts Ratings

Aptabio Therapeutics, Inc. (KR:293780) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

KR:293780 Q2 2026 Earnings Report

KR:293780 Upcoming Earnings
Aptabio Therapeutics, Inc.'s next earnings date is estimated for November 18, 2026, based on past reporting schedules.

KR:293780 Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 18, 2026
2026 (Q3)
- / -
-114.133
Aug 14, 2026
2026 (Q2)
- / 39.71
-157.243125.25% (+196.95)
May 15, 2026
2026 (Q1)
- / -229.41
-95.956-139.07% (-133.45)
Mar 23, 2026
2025 (Q4)
- / -240.15
-404.30340.60% (+164.15)
Nov 14, 2025
2025 (Q3)
- / -114.13
-347.9967.20% (+233.86)
Aug 14, 2025
2025 (Q2)
- / -157.24
-301.35447.82% (+144.11)
May 15, 2025
2025 (Q1)
- / -95.96
-169.9843.55% (+74.02)
Mar 18, 2025
2024 (Q4)
- / -404.30
-356.006-13.57% (-48.30)
Nov 14, 2024
2024 (Q3)
- / -347.99
-183.546-89.59% (-164.44)
Aug 14, 2024
2024 (Q2)
- / -301.35
-96.51-212.25% (-204.84)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

KR:293780 Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 14, 2026
₩6060.00₩6180.00+1.98%
May 15, 2026
₩7040.00₩6930.00-1.56%
Mar 23, 2026
₩7020.00₩6750.00-3.85%
Nov 14, 2025
₩7960.00₩7830.00-1.63%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Aptabio Therapeutics, Inc. (KR:293780) report earnings?
Aptabio Therapeutics, Inc. (KR:293780) is schdueled to report earning on Nov 18, 2026, TBA (Confirmed).
    What is Aptabio Therapeutics, Inc. (KR:293780) earnings time?
    Aptabio Therapeutics, Inc. (KR:293780) earnings time is at Nov 18, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Aptabio Therapeutics, Inc. stock?
          The P/E ratio of Aptabio Therapeutics, Inc. is N/A.
            What is KR:293780 EPS forecast?
            Currently, no data Available